IRIS
MARONGIU, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 284
EU - Europa 141
AS - Asia 86
AF - Africa 2
OC - Oceania 2
Totale 515
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 283
IT - Italia 92
HK - Hong Kong 61
UA - Ucraina 22
CN - Cina 16
DE - Germania 9
FR - Francia 6
IL - Israele 4
FI - Finlandia 3
SE - Svezia 3
TR - Turchia 3
AU - Australia 2
BE - Belgio 2
GB - Regno Unito 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
CA - Canada 1
CI - Costa d'Avorio 1
IN - India 1
LU - Lussemburgo 1
ZA - Sudafrica 1
Totale 515
Salva come PNG Salva come JPEG
Città #
Chandler 78
Hong Kong 58
West Jordan 18
Princeton 14
Alghero 12
Jacksonville 12
New York 12
Sassari 11
Ashburn 7
Wilmington 7
Ann Arbor 6
Dearborn 6
Nanjing 6
Seattle 6
Selargius 6
Beijing 5
Milan 5
Cagliari 4
Helsinki 3
Salerno 3
Torino 3
Agrigento 2
Boardman 2
Brussels 2
Città Di Castello 2
Istanbul 2
Jerusalem 2
Melbourne 2
Nanchang 2
Tel Aviv 2
Abidjan 1
Bologna 1
Burgas 1
Como 1
Dubai 1
Gauteng 1
Hangzhou 1
Hebei 1
Legnano 1
Luxembourg 1
Ningbo 1
Ottawa 1
Padova 1
Pune 1
Roubaix 1
Santena 1
Stockholm 1
Washington 1
Woodbridge 1
Totale 319
Salva come PNG Salva come JPEG
Nome #
131I-SPECT/CT in neck lymph node metastasis detection in patients with differentiated thyroid carcinomas (DTC) in long-term follow-up 59
Qualitative (Q) and semiquantitative (SQ) brain 18FFDG PET analyses in primary progressive aphasia (PPA) variants 52
Neck lymph node metastases in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a diagnostic 131I-SPECT/CT study 51
Neck lymph node metastasis detection in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a 131I-SPECT/CT study. 39
The diagnostic usefulness of131i-spect/ct at both radioiodine ablation and during long-term follow-up in patients thyroidectomized for differentiated thyroid carcinoma: Analysis of tissue risk factors ascertained at surgery and correlated with metastasis appearance 31
Usefulness of PET/CT with 18F-FDG in Patients with Differentiated Thyroid Carcinoma after Radioiodine Therapy: An Italian Multicenter Study 29
Brain 123I-ioflupane SPECT and 18F-FDG PET combined use in movement and cognitive associated diseases of recent appearance 26
131I-SPECT/CT after radioiodine therapy in patients with differentiated thyroid carcinoma 25
The role of routine 131I-SPECT/CT use in differentiated thyroid carcinoma (DTC) follow-up 22
Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer 18
Hashimoto's Thyroiditis and Papillary Thyroid Carcinoma: A Follow-Up Study in Patients with Absence of Aggressive Risk Factors at the Surgery of the Primary Tumor 15
Axillary lymph node hypermetabolism (ALNH) related to COVID-19 vaccination in cancer patients undergoing 18F-FDG PET/CT: a single centre study on 500 cases 14
131I-SPECT/CT usefulness in patients with Hashimoto’s thyroiditis (HT) coexistence with papillary thyroid carcinoma (PC) without risk factors at surgery followed in a long-term follow-up after thyroidectomy and radioiodine ablation 14
Cortical metabolic 18F-FDG PET assessment and striatal dopamine transporter SPECT imaging in suspected early neurodegenerative disorders with uncertain movement and cognitive symptoms 13
Breast-Specific Gamma Imaging: An Added Value in the Diagnosis of Breast Cancer, a Systematic Review 13
131I-SPECT/CT at the first radioiodine ablation and during follow-up in patients with differentiated thyroid carcinoma (DTC). 13
First-, Second-, and Third-Generation Radiolabeled Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Positron Emission Tomography: State of the Art, a Systematic Review 12
Brain 18F-FDG PET/CT usefulness in primary progressive aphasia variant diagnosis and in their development into Alzheimer’s disease or fronto-temporal dementia 11
A Comparative Follow-Up Study of Patients with Papillary Thyroid Carcinoma Associated or Not with Graves' Disease 9
Qualitative and semiquantitative parameters in solitary pulmonary nodule: a multicenter 18F-FDG-PET/CT study 9
Differential Diagnosis of Alzheimer Disease vs. Mild Cognitive Impairment Based on Left Temporal Lateral Lobe Hypomethabolism on 18F-FDG PET/CT and Automated Classifiers 8
Pet-radiomics in lymphoma and multiple myeloma: update of current literature 8
18F-FDG brain and whole body (WB) PET/CT in intracranial leptomeningeal carcinomatosis and in paraneoplastic neurologic syndromes 8
Performance Analysis of Six Semi-Automated Tumour Delineation Methods on [18F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) in Patients with Head and Neck Cancer 7
Qualitative and Semiquantitative Parameters of 18F-FDG-PET/CT as Predictors of Malignancy in Patients with Solitary Pulmonary Nodule 7
Prognostic role of minimal extrathyroidal tumor extension (mETE) in the follow-up of patients with papillary carcinoma (PC) unaffected by other risk factors. 7
Radiomics analysis on PET/CT scans to discriminate malignant (adenocarcinoma) and benign pulmonary nodules 7
A multicenter 18F-FDG-PET/CT study in solitary pulmonary nodule: Qualitative and Semiquantitative parameters to predict the risk of malignancy 7
The DASciS Software for BSI Calculation as a Valuable Prognostic Tool in mCRPC Treated with 223RaCl2: A Multicenter Italian Study 7
123I-Ioflupane brain SPECT (I-SPECT) and brain parenchyma sonography (BPS) combined use in movement disorder diagnosis 6
A multicenter study for the analysis of early onset Parkinson’s disease population: the role of 123I-FP-CIT and 123I-MIBG 6
Long-term follow-up of patients thyroidectomized for thyroid papillary carcinoma (PC) with associated Graves’s disease (GD): a 131I-SPECT/CT diagnostic study 5
Evaluation of Bone Scan Index as a Prognostic Tool in Breast Cancer Patients with Bone Metastasis 5
123I-MIBG Cardiac Scintigraphy and Heart/Mediastinum Ratio in Neurodegenerative Disorders: Is Delayed Scan Really Necessary? 5
Role of Functional Neuroimaging with 123I-MIBG and 123I-FP-CIT in De Novo Parkinson's Disease: A Multicenter Study 3
Minimal Extrathyroid Extension (mETE) as the Only Risk Factor in Patients with Papillary Thyroid Carcinoma (PC): Its Clinical Impact on Recurrence and Outcome during Long-Term Follow-Up 1
Totale 572
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.386
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.386
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20194 0 0 0 0 0 0 0 0 0 0 2 2
2019/202049 7 1 0 5 4 5 7 2 4 8 4 2
2020/202142 4 0 4 5 13 0 5 0 5 6 0 0
2021/202243 5 2 8 0 0 2 0 3 2 2 2 17
2022/2023153 8 14 2 35 8 30 4 15 26 2 6 3
2023/2024274 42 28 9 33 94 41 0 6 1 20 0 0
Totale 572